A

Altevax Biotech

4 employees

Altevax is developing a technology in cancer vaccines.

Basic info

Industry

pharmaceutical manufacturing

Sectors

CD8 Killer T cells
Cancer vaccines
Biotechnology
therapeutic vaccines
melanin
infectious diseases
immunotherapy
Peptidic vaccines

Date founded

2016

Funding rounds raised

A

Altevax Biotech raised undisclosed on July 1, 2016

Investors: Agoranov

FAQ